These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24304197)

  • 1. Emerging trabecular outflow drugs.
    Kopczynski CC; Epstein DL
    J Ocul Pharmacol Ther; 2014; 30(2-3):85-7. PubMed ID: 24304197
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in glaucoma diagnosis and therapy for the next millennium: new drugs for trabecular and uveoscleral outflow.
    Kaufman PL; Gabelt B; Tian B; Liu X
    Semin Ophthalmol; 1999 Sep; 14(3):130-43. PubMed ID: 10790577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in glaucoma treatment and management: outflow drugs.
    Kaufman PL; Rasmussen CA
    Invest Ophthalmol Vis Sci; 2012 May; 53(5):2495-500. PubMed ID: 22562850
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs and the trabecular meshwork.
    Kaufman PL
    Invest Ophthalmol Vis Sci; 1977 Jun; 16(6):475-7. PubMed ID: 16830
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model.
    Wang F; Ma F; Song Y; Li N; Li X; Pang Y; Hu P; Shao A; Deng C; Zhang X
    Eur J Pharmacol; 2020 Oct; 884():173369. PubMed ID: 32712092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical treatment of glaucoma: established and emerging pharmacology.
    Dikopf MS; Vajaranant TS; Edward DP
    Expert Opin Pharmacother; 2017 Jun; 18(9):885-898. PubMed ID: 28480761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of glaucoma by prostaglandin agonists and beta-blockers in combination directly reduces pro-fibrotic gene expression in trabecular meshwork.
    Tejwani S; Machiraju P; Nair AP; Ghosh A; Das RK; Ghosh A; Sethu S
    J Cell Mol Med; 2020 May; 24(9):5195-5204. PubMed ID: 32267082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trabecular meshwork as a new target for the treatment of glaucoma.
    Ferrer E
    Drug News Perspect; 2006 Apr; 19(3):151-8. PubMed ID: 16804567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Transport of Lipid Metabolites Within Trabecular Meshwork Cells.
    Toglia D; Dancausse S; Kalahasty K; Alfonso B; Bhattacharya SK
    Methods Mol Biol; 2019; 1996():187-197. PubMed ID: 31127557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer targets for modulation of intraocular pressure: focus on adenosine receptor signaling pathways.
    Agarwal R; Agarwal P
    Expert Opin Ther Targets; 2014 May; 18(5):527-39. PubMed ID: 24579961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructure of the trabecular meshwork in secondary glaucoma eyes after intravitreal triamcinolone acetonide.
    Kubota T; Okabe H; Hisatomi T; Yamakiri K; Sakamoto T; Tawara A
    J Glaucoma; 2006 Apr; 15(2):117-9. PubMed ID: 16633224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma.
    Wordinger RJ; Clark AF
    Prog Retin Eye Res; 1999 Sep; 18(5):629-67. PubMed ID: 10438153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src mediates TGF-β-induced intraocular pressure elevation in glaucoma.
    Tsukamoto T; Kajiwara K; Nada S; Okada M
    J Cell Physiol; 2019 Feb; 234(2):1730-1744. PubMed ID: 30144071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trabecular meshwork ECM remodeling in glaucoma: could RAS be a target?
    Agarwal P; Agarwal R
    Expert Opin Ther Targets; 2018 Jul; 22(7):629-638. PubMed ID: 29883239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethacrynic acid: outflow effects and toxicity in human trabecular meshwork in perfusion organ culture.
    Johnson DH; Tschumper RC
    Curr Eye Res; 1993 May; 12(5):385-96. PubMed ID: 8344063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The trabecular meshwork: Structure, function and clinical implications. A review of the littérature (French translation of the article)].
    Buffault J; Labbé A; Hamard P; Brignole-Baudouin F; Baudouin C
    J Fr Ophtalmol; 2020 Oct; 43(8):779-793. PubMed ID: 32807552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue.
    Clark AF; Brotchie D; Read AT; Hellberg P; English-Wright S; Pang IH; Ethier CR; Grierson I
    Cell Motil Cytoskeleton; 2005 Feb; 60(2):83-95. PubMed ID: 15593281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphopathological changes in glaucoma-induced trabecular meshwork].
    Petraru D; Indrei A; Costin D; Mihalache G
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):894-8. PubMed ID: 22046805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hyaluronidase on aqueous outflow resistance in normotensive and glaucomatous eyes of dogs.
    Gum GG; Samuelson DA; Gelatt KN
    Am J Vet Res; 1992 May; 53(5):767-70. PubMed ID: 1524304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future target molecules in antiglaucoma therapy: tgf-Beta may have a role to play.
    Agarwal R; Agarwal P
    Ophthalmic Res; 2010; 43(1):1-10. PubMed ID: 19829006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.